GlassScriptPhysician profile
Kathleen Vine
NPI 1659534410
$10,449.82
in general payments reported to CMS, 2019-2025
42 companies · $2,129 in 2025
The $2,129 reported for 2025 was more than what 77% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,319 · 2020: $630 · 2021: $1,242 · 2022: $1,310 · 2023: $2,046 · 2024: $1,773 · 2025: $2,129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,854 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,853.55 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,228.67 | 2019-2025 | Skyrizi, Rinvoq |
| Janssen Biotech, INC. | $951.28 | 2019-2025 | Tremfya, Stelara, Simponi |
| Galderma Laboratories, L.P. | $814.33 | 2019-2025 | Nemluvio |
| Lilly USA, LLC | $574.31 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Amgen INC. | $540.57 | 2020-2024 | Otezla |
| Biofrontera INC. | $506.26 | 2019-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Novartis Pharmaceuticals Corporation | $458.24 | 2021-2025 | |
| Dermavant Sciences, INC. | $448.12 | 2023-2024 | Vtama |
| Incyte Corporation | $441.41 | 2022-2025 | Opzelura, Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $427.96 | 2019-2025 | Jublia, Cabtreo, Siliq |
| Almirall LLC | $414.52 | 2019-2025 | Seysara, Klisyri |
| Arcutis Biotherapeutics, INC. | $384.58 | 2023-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $361.25 | 2019-2025 | |
| Pfizer INC. | $281.76 | 2019-2024 | |
| Genzyme Corporation | $279.65 | 2022-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Vine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.